Investigating the Interaction Between the Mammalian Circadian Clock and Extracellular Vesicles in the Progression of Pancreatic Cancer
Files
TR Number
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with a 5-year survival of <10%. The poor outcome in PDAC patients is due, in part, to high rates of metastasis and the development of cachexia, a multi-system metabolic disorder characterized by significant weight loss, systemic inflammation, and muscle atrophy. While previous studies have suggested that circadian clock dysregulation is associated with worse overall outcomes in cancer patients, the role of circadian dysregulation in muscle atrophy in the context of pancreatic cancer is not well understood. We hypothesized that PDAC-derived extracellular vesicles (EVs) disrupt circadian-controlled homeostasis to further drive PDAC progression and muscle atrophy. Our findings show that PDAC-derived EVs are capable of inducing circadian dysregulation of cells in vitro. Using a real-time bioluminescence reporter system, we found that NIH3T3 BMAL:Luc fibroblasts treated with secreted factors from PDAC cells exhibited an altered circadian period. Accordingly, gene expression analysis revealed disruption of core clock transcripts in NIH3T3 fibroblasts and C2C12 myotubes, including BMAL1 and PER2, in response to PDAC-derived conditioned media. We next sought to determine the role of PDAC-EVs in muscle cells, and found that treatment with secreted factors from PDAC cells was sufficient to induce circadian dysregulation and myotube atrophy in vitro. To further investigate the role of EVs in circadian dysregulation and atrophy, EVs were collected and RNA-seq performed to identify candidate miRNAs that contribute to circadian dysregulation and atrophy. Our results show a time-dependent variability in the number of EVs and their miRNA composition. Cells were then transfected with candidate miRNA mimics and the effects on the circadian clock and muscle cell function were investigated. Several miRNAs were found to either alter the circadian period or induce myotube atrophy. Together, these findings provide valuable insight into the role of PDAC-derived EVs in circadian dysregulation, cellular migration, and myotube atrophy in the context of pancreatic cancer. A better understanding of the relationship between EVs, circadian dysregulation, and pancreatic cancer could lead to the identification of novel EV-based biomarkers for early detection of pancreatic cancer or risk of developing cachexia.